Lateral Flow Assay Market Surging at 5% CAGR; Persistence Market Research Forecasts US$ 13.7 Bn Valuation by 2032

The global lateral flow assay (LFA) market is experiencing significant growth, driven by the increasing demand for rapid diagnostic testing across various industries such as healthcare, food & feed testing, environmental testing, and animal health. By the end of 2021, the global market for lateral flow assays had reached a valuation of US$ 7.9 billion, with projections indicating an impressive compound annual growth rate (CAGR) of 5% through 2032. The market is expected to grow to US$ 13.7 billion by the end of the forecast period.

This surge in demand for lateral flow assays can be attributed to several key factors, including the growing prevalence of infectious diseases, the increasing acceptance of self-testing, and the market's ability to deliver accurate, fast, and cost-effective diagnostic solutions. As the demand for such tests grows, manufacturers are increasingly focusing on innovation, regulatory approvals, and collaborations to strengthen their market position.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/18613

Overview of the Market

The lateral flow assay market is a rapidly expanding sector within the point-of-care (POC) diagnostic industry. As of 2021, lateral flow assay products contributed a substantial 71.3% to the global POC market. These assays are designed to provide quick, easy, and cost-effective diagnostic results, which is why they have found widespread use in applications such as infectious disease diagnosis, pregnancy tests, drug abuse screening, and more. The global LFA market is dominated by a few key players, with innovations driving rapid advancements in testing technologies.

Lateral flow assays function based on the principle of immunoassays and are typically used for qualitative and semi-quantitative detection of specific substances such as antigens or antibodies. One of the reasons behind their increasing popularity is their ease of use, low-cost production, and the ability to perform rapid tests outside clinical settings. For instance, LFA tests are commonly used in home-based settings for pregnancy and COVID-19 testing, where the speed and accuracy of results are of paramount importance.

Key Highlights from the Report

➤ The global lateral flow assay market was valued at US$ 7.9 billion in 2021.
➤ The market is expected to grow at a CAGR of 5% between 2022 and 2032.
➤ Lateral flow assay products accounted for 71.3% of the point-of-care diagnostics market in 2021.
➤ The market share of the top 5 countries accounts for 60.9% of the global lateral flow assay market.
➤ The demand for lateral flow assays in infectious disease testing is rising rapidly, especially due to the COVID-19 pandemic.
➤ Companies such as Abbott, Siemens Healthineers, and Thermo Fisher Scientific dominate the LFA market.

Market Segmentation

The lateral flow assay market can be segmented in various ways, including by product type, end-user, and application.

By Product Type:

Lateral flow assay products primarily fall into two categories: LFA kits and LFA readers. The LFA kits segment is the leading contributor, with a market share of about 76.5% in 2021. This is because LFA kits are extensively used for self-testing, allowing individuals to diagnose conditions such as pregnancy, infectious diseases (e.g., COVID-19, malaria), and even foodborne illnesses. The increasing popularity of at-home testing is significantly driving the growth of this segment. Additionally, the availability of smartphone-based LFA tests is expected to enhance the accessibility of these products globally, particularly in emerging markets.

By Application:

The largest application segment of lateral flow assays is in the diagnosis of infectious diseases, which accounted for 37.6% of the market in 2021. The rapid growth in infectious disease testing, including the detection of COVID-19, HIV, malaria, and other seasonal outbreaks, has led to increased demand for lateral flow assays. The demand for diagnostic kits has skyrocketed, particularly during the COVID-19 pandemic. In addition, LFA tests have gained significant traction in food safety and drug abuse screening due to their ability to deliver quick results.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/lateral-flow-assays-market.asp

Regional Insights

North America:

In 2021, North America accounted for the largest share of the global lateral flow assay market, with the U.S. leading the charge. The U.S. alone held a staggering 91.8% market share in the region. This dominance is attributed to the country's robust healthcare infrastructure, high adoption rates of point-of-care diagnostics, and government support for rapid diagnostic testing, especially in the wake of the COVID-19 pandemic. Significant investments, such as the US$ 650 million allocated by the U.S. Department of Health and Human Services in 2021, have bolstered the development and distribution of lateral flow assays in the region.

Europe:

In Europe, the U.K. is emerging as a key player, holding about 16.8% of the European market share in 2021. The government's efforts to encourage the use of rapid lateral flow tests for COVID-19 detection have contributed significantly to market growth in the region. The U.K.'s widespread testing programs, including the promotion of free at-home tests, have driven the demand for lateral flow assays. Other European countries are also increasingly adopting these tests, further supporting market expansion.

Asia-Pacific:

In the Asia-Pacific (APAC) region, China is leading the lateral flow assay market, holding 46.3% of the East Asia market share in 2021. The government's efforts to monitor infectious disease outbreaks and launch affordable rapid diagnostic tests have greatly impacted the demand for lateral flow assays. Furthermore, the growing acceptance of smartphone-based devices in China for real-time diagnostics is expected to propel the market in the coming years.

Market Drivers

Several factors contribute to the growth of the lateral flow assay market.

Increasing Prevalence of Infectious Diseases: The growing global burden of infectious diseases such as COVID-19, HIV, malaria, and sexually transmitted diseases (STDs) has significantly contributed to the demand for rapid diagnostic testing. As per the World Health Organization (WHO), the prevalence of sexually transmitted infections (STIs) such as chlamydia and gonorrhea is on the rise, increasing the need for accessible testing solutions like lateral flow assays.

Rising Demand for Self-Testing: The shift towards self-testing is a key driver of the lateral flow assay market. People increasingly prefer to perform tests at home to diagnose conditions such as pregnancy, COVID-19, and diabetes. The convenience, affordability, and speed of lateral flow assays make them ideal for this purpose.

Market Restraints

Despite the promising growth, the lateral flow assay market faces challenges:

Quality Control Issues: One of the main drawbacks of lateral flow assays is their tendency to suffer from inconsistent results. Variations in sample volumes or improper sample handling can lead to inaccurate readings, potentially hindering the reliability of these tests.

Market Saturation & Competition: As the demand for lateral flow assays grows, the market is becoming increasingly competitive. Vendors are focusing on reducing the cost of production, which sometimes leads to the availability of sub-standard products that do not meet the required performance standards.

Market Opportunities

Emerging Markets: Lower-middle-income countries are expected to drive substantial market growth due to the affordable pricing of lateral flow assays. Additionally, the growing awareness and healthcare infrastructure improvements in these regions offer untapped potential for expansion.

Technological Advancements: The integration of smartphone-based diagnostics and digital health tools with lateral flow assays presents significant opportunities for market growth. Consumers can now access real-time results through mobile apps, enabling quicker decision-making and follow-up actions.

Collaborative Efforts in R&D: Ongoing collaborations between pharmaceutical companies, healthcare providers, and governments are likely to accelerate the development of more effective, affordable, and accessible lateral flow assay products.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/18613

Reasons to Buy the Report

✔ Understand the market dynamics and growth drivers shaping the lateral flow assay industry.
✔ Gain insights into the competitive landscape and key players shaping the market.
✔ Evaluate current and future trends influencing lateral flow assay adoption.
✔ Assess market segmentation by product type, end-users, and applications.
✔ Identify emerging opportunities and growth potential across key regions.

Company Insights

✦ Thermo Fisher Scientific Inc.
✦ F. Hoffmann-La Roche
✦ Abbott Laboratories
✦ PerkinElmer Inc.
✦ Siemens Healthineers
✦ QIAGEN N.V.
✦ bioMérieux SA
✦ Bio-Rad Laboratories, Inc.
✦ Quidel Corporation
✦ Meridian Bioscience Inc.

Recent Developments:

In February 2021, PerkinElmer launched a COVID-19 antigen test for rapid detection.

In October 2020, Siemens Healthineers introduced the CLINITEST Rapid COVID-19 antigen self-test for the detection of COVID-19 infections.

Conclusion

The lateral flow assay market is positioned for sustained growth, fueled by its critical role in rapid diagnostic testing across diverse applications such as infectious disease detection, pregnancy testing, and self-testing. The market's projected growth at a CAGR of 5% from 2022 to 2032, alongside its increasing penetration in point-of-care (POC) diagnostics, underscores its importance in modern healthcare systems. As demand for rapid, affordable, and accurate testing solutions continues to rise, particularly in emerging markets, the lateral flow assay market presents significant opportunities for manufacturers and healthcare providers alike.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.